Krystal Biotech Inc (KRYS) — Financial Flexibility Index
Krystal Biotech Inc (KRYS) has a Financial Flexibility Index of 0.55x as of June 2026. Free cash flow of $78.35 Million (operating CF $74.79 Million minus capex $3.56 Million) represents 1% of total liabilities ($141.52 Million). Check Krystal Biotech Inc (KRYS) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Krystal Biotech Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Krystal Biotech Inc across 10 annual periods. For the full cash flow conversion analysis, see KRYS operating cash flow.
Annual Financial Flexibility Index for Krystal Biotech Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Krystal Biotech Inc. Explore how well can Krystal Biotech Inc service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.86x | $212.82 Million | $200.87 Million | $114.23 Million | ▲ +59.7% |
| 2024 | 1.17x | $127.66 Million | $123.42 Million | $109.46 Million | ▲ +160.1% |
| 2023 | -1.94x | $-77.00 Million | $-88.80 Million | $39.71 Million | ▼ -47.6% |
| 2022 | -1.31x | $-47.59 Million | $-100.57 Million | $36.22 Million | ▼ -310.8% |
| 2021 | 0.62x | $20.40 Million | $-47.94 Million | $32.72 Million | ▲ +204.1% |
| 2020 | -0.60x | $-11.24 Million | $-26.08 Million | $18.76 Million | ▲ +70.3% |
| 2019 | -2.02x | $-12.31 Million | $-18.71 Million | $6.11 Million | ▲ +19.2% |
| 2018 | -2.50x | $-7.21 Million | $-9.45 Million | $2.89 Million | ▲ +56.6% |
| 2017 | -5.75x | $-3.68 Million | $-3.89 Million | $640.00K | ▼ -739.9% |
| 2016 | -0.68x | $-1.30 Million | $-1.31 Million | $1.89 Million | — |